{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:23:51Z","timestamp":1762863831794,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"vor","delay-in-days":908,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01 NS041588"],"award-info":[{"award-number":["U01 NS041588"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01 NS041588"],"award-info":[{"award-number":["U01 NS041588"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1002\/rth2.12365","type":"journal-article","created":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T19:55:57Z","timestamp":1592164557000},"page":"893-901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["N\u2010Terminal pro\u2010B\u2010type natriuretic peptide and stroke risk across a spectrum of cerebrovascular disease: The REasons for Geographic and Racial Differences in Stroke cohort"],"prefix":"10.1016","volume":"4","author":[{"given":"Suzanne E.","family":"Judd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn O.","family":"Kleindorfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia J.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil A.","family":"Zakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara K.","family":"Landry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/rth2.12365_bb0010","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics\u20102017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"10.1002\/rth2.12365_bb0015","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1212\/01.WNL.0000042780.64786.EF","article-title":"A comparison of risk factors for recurrent TIA and stroke in patients diagnosed with TIA","volume":"60","author":"Johnston","year":"2003","journal-title":"Neurology"},{"key":"10.1002\/rth2.12365_bb0020","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ana.21357","article-title":"Care seeking after stroke symptoms","volume":"63","author":"Howard","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1002\/rth2.12365_bb0025","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinte.166.18.1952","article-title":"High prevalence of stroke symptoms among persons without a diagnosis of stroke or transient ischemic attack in a general population: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study","volume":"166","author":"Howard","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1002\/rth2.12365_bb0030","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/01.STR.0000158917.59233.b7","article-title":"Incidence and short\u2010term prognosis of transient ischemic attack in a population\u2010based study","volume":"36","author":"Kleindorfer","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/rth2.12365_bb0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/STROKEAHA.112.675033","article-title":"Self\u2010report of stroke, transient ischemic attack, or stroke symptoms and risk of future stroke in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study","volume":"44","author":"Judd","year":"2013","journal-title":"Stroke"},{"key":"10.1002\/rth2.12365_bb0040","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/jnnp.74.5.577","article-title":"Long term risks of stroke, myocardial infarction, and vascular death in \"low risk\" patients with a non\u2010recent transient ischaemic attack","volume":"74","author":"Clark","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1002\/rth2.12365_bb0045","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1161\/STROKEAHA.110.612937","article-title":"Self\u2010reported stroke symptoms without a prior diagnosis of stroke or transient ischemic attack: a powerful new risk factor for stroke","volume":"42","author":"Kleindorfer","year":"2011","journal-title":"Stroke"},{"key":"10.1002\/rth2.12365_bb0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000073972","article-title":"Association between symptoms reported in a population questionnaire and future ischemic stroke: the ARIC study","volume":"23","author":"Chambless","year":"2004","journal-title":"Neuroepidemiology"},{"key":"10.1002\/rth2.12365_bb0055","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/STROKEAHA.111.643379","article-title":"Covert neurological symptoms associated with silent infarcts from midlife to older age: the Atherosclerosis Risk in Communities study","volume":"43","author":"Windham","year":"2012","journal-title":"Stroke"},{"key":"10.1002\/rth2.12365_bb0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/jth.13562","article-title":"Association of stroke risk biomarkers with stroke symptoms: the Reasons for Geographic and Racial Differences in Stroke cohort","volume":"15","author":"Landry","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12365_bb0065","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/STR.0b013e3181f7d043","article-title":"Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Furie","year":"2011","journal-title":"Stroke"},{"key":"10.1002\/rth2.12365_bb0070","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/STROKEAHA.113.003077","article-title":"ABCD3 and ABCD3\u2010I scores are superior to ABCD2 score in the prediction of short\u2010 and long\u2010term risks of stroke after transient ischemic attack","volume":"45","author":"Kiyohara","year":"2014","journal-title":"Stroke"},{"key":"10.1002\/rth2.12365_bb0075","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"issue":"7","key":"10.1002\/rth2.12365_bb0080","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001646","article-title":"Traditional risk factors versus biomarkers for prediction of secondary events in patients with stable coronary heart disease: from the Heart and Soul Study","volume":"4","author":"Beatty","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1002\/rth2.12365_bb0085","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/14779072.2017.1355238","article-title":"Atrial cardiopathy: a mechanism of cryptogenic stroke","volume":"15","author":"Yaghi","year":"2017","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1002\/rth2.12365_bb0090","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1161\/STROKEAHA.114.004712","article-title":"N\u2010terminal pro\u2010B\u2010type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort","volume":"45","author":"Cushman","year":"2014","journal-title":"Stroke"},{"key":"10.1002\/rth2.12365_bb0095","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/STROKEAHA.111.000173","article-title":"Troponin T, N\u2010terminal pro\u2010B\u2010type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study","volume":"44","author":"Folsom","year":"2013","journal-title":"Stroke"},{"key":"10.1002\/rth2.12365_bb0100","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.109.873265","article-title":"N\u2010terminal pro\u2010B\u2010type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study","volume":"120","author":"Patton","year":"2009","journal-title":"Circulation"},{"key":"10.1002\/rth2.12365_bb0105","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIRCULATIONAHA.109.882241","article-title":"Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community","volume":"121","author":"Schnabel","year":"2010","journal-title":"Circulation"},{"key":"10.1002\/rth2.12365_bb0110","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.111.038729","article-title":"Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long\u2010term Anticoagulation Therapy (RE\u2010LY) substudy","volume":"125","author":"Hijazi","year":"2012","journal-title":"Circulation"},{"key":"10.1002\/rth2.12365_bb0115","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehw054","article-title":"The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker\u2010based risk score for predicting stroke in atrial fibrillation","volume":"37","author":"Hijazi","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1002\/rth2.12365_bb0120","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1161\/STROKEAHA.113.003338","article-title":"Usefulness of N\u2010terminal pro\u2010B\u2010type natriuretic peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation","volume":"45","author":"Rold\u00e1n","year":"2014","journal-title":"Stroke"},{"key":"10.1002\/rth2.12365_bb0125","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/STROKEAHA.114.007624","article-title":"Biomarkers and mortality after transient ischemic attack and minor ischemic stroke: population\u2010based study","volume":"46","author":"Greisenegger","year":"2015","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/rth2.12365_bb0130","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3233\/JAD-160328","article-title":"N\u2010terminal pro\u2010B\u2010type natriuretic peptide and risk of future cognitive impairment in the REGARDS cohort","volume":"54","author":"Cushman","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1002\/rth2.12365_bb0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clineuro.2014.09.028","article-title":"Brain natriuretic peptide level on admission predicts recurrent stroke after discharge in stroke survivors with atrial fibrillation","volume":"127","author":"Shibazaki","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1002\/rth2.12365_bb0140","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/archneur.63.1.noc50221","article-title":"Soluble vascular cell adhesion molecule 1 and N\u2010terminal pro\u2010B\u2010type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease","volume":"63","author":"Campbell","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1002\/rth2.12365_bb0145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000086678","article-title":"The reasons for geographic and racial differences in stroke study: objectives and design","volume":"25","author":"Howard","year":"2005","journal-title":"Neuroepidemiology"},{"key":"10.1002\/rth2.12365_bb0150","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.clinbiochem.2014.08.003","article-title":"Validating laboratory results in a national observational cohort study without field centers: the Reasons for Geographic and Racial Differences in Stroke cohort","volume":"47","author":"Gillett","year":"2014","journal-title":"Clin Biochem"},{"key":"10.1002\/rth2.12365_bb0155","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/hs1001.096191","article-title":"Validating the Questionnaire for Verifying Stroke\u2010Free Status (QVSFS) by neurological history and examination","volume":"32","author":"Jones","year":"2001","journal-title":"Stroke"},{"key":"10.1002\/rth2.12365_bb0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1212\/WNL.0b013e31829a352e","article-title":"Report of stroke\u2010like symptoms predicts incident cognitive impairment in a stroke\u2010free cohort","volume":"81","author":"Kelley","year":"2013","journal-title":"Neurology"},{"key":"10.1002\/rth2.12365_bb0165","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijcard.2016.06.030","article-title":"Stroke symptoms and risk for incident coronary heart disease in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study","volume":"220","author":"Colantonio","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1002\/rth2.12365_bb0170","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.04.009","article-title":"What stroke symptoms tell us: association of risk factors and individual stroke symptoms in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study","volume":"21","author":"Gao","year":"2012","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1002\/rth2.12365_bb0175","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/ana.22385","article-title":"Disparities in stroke incidence contributing to disparities in stroke mortality","volume":"69","author":"Howard","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1002\/rth2.12365_bb0180","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jelectrocard.2009.10.002","article-title":"Calculating Cornell voltage from nonstandard chest electrode recording site in the Reasons for Geographic and Racial Differences in Stroke study","volume":"43","author":"Soliman","year":"2010","journal-title":"J Electrocardiol"},{"key":"10.1002\/rth2.12365_bb0185","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.STR.20.10.1407","article-title":"Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and Other Cerebrovascular Disorders","volume":"20","year":"1989","journal-title":"Stroke"},{"key":"10.1002\/rth2.12365_bb0190","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","article-title":"Plasma natriuretic peptide levels and the risk of cardiovascular events and death","volume":"350","author":"Wang","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1002\/rth2.12365_bb0195","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.amjcard.2003.07.010","article-title":"Brain natriuretic peptide is elevated in outpatients with atrial fibrillation","volume":"92","author":"Silvet","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1002\/rth2.12365_bb0200","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1056\/NEJMoa055373","article-title":"Multiple biomarkers for the prediction of first major cardiovascular events and death","volume":"355","author":"Wang","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1002\/rth2.12365_bb0205","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/STROKEAHA.112.675942","article-title":"Amino terminal pro\u2010B\u2010type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy","volume":"44","author":"Longstreth","year":"2013","journal-title":"Stroke"},{"key":"10.1002\/rth2.12365_bb0210","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.2009.943","article-title":"Novel and conventional biomarkers for prediction of incident cardiovascular events in the community","volume":"302","author":"Melander","year":"2009","journal-title":"JAMA"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Frth2.12365","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12365","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12365","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922020362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922020362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:20:13Z","timestamp":1762863613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922020362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2475037922020362"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12365","relation":{},"ISSN":["2475-0379"],"issn-type":[{"type":"print","value":"2475-0379"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N\u2010Terminal pro\u2010B\u2010type natriuretic peptide and stroke risk across a spectrum of cerebrovascular disease: The REasons for Geographic and Racial Differences in Stroke cohort","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}